2374 J . Org. Chem., Vol. 63, No. 7, 1998
Notes
N-(ter t-Bu toxyca r bon yl)-D-p h en ylglycin e Meth yl Ester
(D-7b). The N-hydroxy-R-amino acid derivative D-6b (0.20 g,
0.638 mmol) was treated as described above for the preparation
of D-7a . Column chromatography (80:20 hexane-diethyl ether)
of the crude product gave 0.162 g (96%) of L-7a as a white solid:
mp 112-114 °C; [R]D -132.3 (c 1.1, CHCl3) [lit. for enantiomer:
(2S,3R)-N-Ben zyl-3-(acetoxyam in o)-1,2-O-isopr opyliden e-
1,2-b u t a n ed iol (11a ). The hydroxylamine 10a (0.70 g, 2.79
mmol) was treated as described above for the preparation of 4a .
Column chromatography (80:20 hexane-diethyl ether) of the
crude product gave 0.816 g (100%) of 11b as an oil: [R]D -9.4 (c
1
1.31, CHCl3); H NMR (CDCl3) δ 1.27 (d, 3H, J ) 6.5 Hz), 1.30
10
1
(s, 3H), 1.34 (s, 3H), 1.81 (s, 3H), 2.96 (dq, 1H, J ) 5.5, 6.5 Hz),
3.91 (d, 1H, J ) 13.5 Hz), 3.92-3.99 (m, 2H), 4.08 (d, 1H, J )
13.5 hz), 4.09-4.15 (m, 1H), 7.20-7.40 (m, 5H); 13C NMR
(CDCl3) δ 9.1, 19.2, 25.2, 26.7, 59.3, 63.0, 68.4, 77.4, 109.1, 127.6,
128.3, 129.1, 136.2, 169.4. Anal. Calcd for C16H23NO4: C, 65.51;
H, 7.90; N, 4.77. Found: C, 65.46; H, 8.11; N, 4.83.
[R]D +135.7 (c 0.8, CHCl3)]; H NMR (CDCl3) δ 1.41 (s, 9H),
3.73 (s, 3H), 5.34 (d, 1H, J ) 7.3 Hz), 5.55 (d, 1H, J ) 7.3 Hz),
7.30-7.44 (m, 5H); 13C NMR (CDCl3) δ 28.3, 52.7, 57.5, 79.90,
127.2, 128.6, 129.1, 137.0, 154.8, 171.6. Anal. Calcd for C14H19
-
NO4: C, 63.38; H, 7.22; N, 5.28. Found: C, 63.44; H, 7.10; N,
5.19.
(2S,3R)-N-Ben zyl-3-(acetoxyam in o)-1,2-O-isopr opyliden e-
3-p h en yl-1,2-p r op a n ed iol (11b). The hydroxylamine 10b
(0.80 g, 2.55 mmol) was treated as described above for the
preparation of 4a . Column chromatography (80:20 hexane-
diethyl ether) of the crude product gave 0.904 g (100%) of 11b
(2S,3R)-N-Ben zyl-3-(a cet oxya m in o)-3-p h en yl-1,2-p r o-
p a n ed iol (8) a n d (2S,3R)-N-Ben zyl-3-(h yd r oxya m in o)-3-
p h en yl-1,2-p r op a n ed iol (9). A solution of 4b (0.2 g, 0.563
mmol) in MeOH (30 mL) was treated with p-toluenesulfonic acid
monohydrate (19 mg, 0.1 mmol), and the resulting solution was
refluxed for 4 h. After the solution was cooled to ambient
temperature, the solvent was evaporated under reduced pressure
and the residue was partitioned between saturated aqueous
NaHCO3 (30 mL) and EtOAc (30 mL). The aqueous layer was
separated and extracted with EtOAc (3 × 25 mL). The combined
organic extracts were dried (MgSO4) and evaporated under
reduced pressure to give the crude product. 1H NMR analysis
of this crude material revealed an 8:1 mixture of 8 and 9,
respectively. Attempts to purify of this material both by column
chromatography and preparative TLC only afforded enriched
mixtures of the products.
8: 1H NMR (CDCl3 + D2O) (selected signals) δ 2.15 (s, 3H),
3.15 (dd, 1H, J ) 4.3, 11.8 Hz), 3.48 (dd, 1H, J ) 2.8, 11.8 Hz),
3.65 (s, 2H), 3.81 (d, 1H, J ) 9.5 Hz), 4.20 (ddd, 1H, J ) 2.8,
4.3, 9.5 Hz), 7.20-7.45 (m, 5H).
9: 1H NMR (CDCl3 + D2O) (selected signals) δ 3.19 (dd, 1H,
J ) 3.7, 11.6 Hz), 3.56 (dd, 1H, J ) 2.9, 11.6 Hz), 3.69 (s, 2H),
3.86 (d, 1H, J ) 9.8 Hz), 4.26 (ddd, 1H, J ) 2.9, 3.7, 9.8 Hz),
7.20-7.40 (m, 5H).
(2S,3S)-N-Ben zyl-3-(h ydr oxyam in o)-1,2-O-isopr opyliden e-
1,2-bu ta n ed iol (10a ). The nitrone 2 (0.94 g, 4 mmol) was
treated as described above for the preparation of 3a using diethyl
aluminum chloride (4 mmol, 4.0 mL of a 1.0 M solution in
hexanes) as a Lewis acid. 1H NMR analysis of the crude product
revealed a diastereoselectivity of 82%. Column chromatography
(70:30 hexane-diethyl ether) of that crude product gave 0.633
g (63%) of 10a as a white solid: mp 84-86 °C; [R]D -8.3 (c 1.0,
CHCl3); 1H NMR (CDCl3) δ 1.24 (d, 3H, J ) 6.6 Hz), 1.34 (s,
3H), 1.39 (s, 3H), 2.84 (dq, 1H, J ) 6.6, 7.3 Hz), 3.71 (d, 1H, J
) 13.2 Hz), 3.86 (dd, 1H, J ) 6.3, 8.4 Hz), 3.96 (d, 1H, J ) 13.2
Hz), 4.08 (dd, 1H, J ) 6.3, 8.4 Hz), 4.20 (dt, 1H, J ) 6.3, 7.3
Hz), 5.60 (bs, 1H, ex. D2O), 7.26-7.38 (m, 5H); 13C NMR (CDCl3)
δ 9.0, 25.4, 26.7, 61.0, 63.7, 66.7, 76.7, 108.8, 127.3, 128.3, 129.2,
137.7. Anal. Calcd for C14H21NO3: C, 66.91; H, 8.42; N, 5.57.
Found: C, 66.85; H, 8.40; N, 5.77.
1
as a white solid: mp 87-89 °C; [R]D -37.9 (c 0.34, CHCl3); H
NMR (CDCl3) δ 1.22 (s, 3H), 1.24 (s, 3H), 1.85 (s, 3H), 3.71 (d,
1H, J ) 13.3 Hz), 3.81 (d, 1H, J ) 13.3 Hz), 3.84 (d, 1H, J ) 8.1
Hz), 4.10 (dd, 1H, J ) 6.8, 10.6 Hz), 4.16 (dd, 1H, J ) 5.9, 10.6
Hz), 4.51 (ddd, 1H, J ) 5.9, 6.8, 10.6 Hz), 7.22-7.38 (m, 10H);
13C NMR (CDCl3) δ 19.3, 25.2, 26.7, 60.4, 8.4, 72.1, 75.9, 109.3,
127.7, 128.2, 128.3, 128.4, 129.3, 130.4, 135.0, 135.9, 169.7.
Anal. Calcd for C21H25NO4: C, 70.96; H, 7.09; N, 3.94. Found:
C, 71.04; H, 7.13; N, 3.88.
Meth yl (2S)-N-Ben zyl-2-(a cetoxya m in o)p r op a n oa te (L-
6a ). Compound 11a (0.5 g, 1.7 mmol) was treated as described
above for the preparation of D-6a . Column chromatography (80:
20 hexane-diethyl ether) of the residue gave 0.261 g (61%) of
L-6a as an oil: [R]D -10.1 (c 1.7, CHCl3); 1H NMR (CDCl3) δ
1.44 (d, 3H, J ) 6.9 Hz), 1.88 (s, 3H), 3.77 (s, 3H), 3.83 (q, 1H,
J ) 6.9 Hz), 4.11 (d, 1H, J ) 13.3 Hz), 4.21 (d, 1H, J ) 13.3 Hz),
7.24-7.39 (m, 5H); 13C NMR (CDCl3) δ 14.2, 19.0, 51.8, 59.2,
62.8, 127.7, 128.2, 129.5, 135.5, 169.5, 171.4. Anal. Calcd for
C13H17NO4: C, 62.14; H, 6.82; N, 5.57. Found: C, 62.29; H, 6.92;
N, 5.68.
Met h yl (2S)-N-Ben zyl-2-(a cet oxya m in o)-2-p h en ylet h -
a n oa te (L-6b). Compound 11b (0.604 g, 1.7 mmol) was treated
as described above for the preparation of D-6b. Column chro-
matography (80:20 hexane-diethyl ether) of the residue gave
1
0.346 g (65%) of L-6b as an oil: [R]D +24.5 (c 1.10, CHCl3); H
NMR (CDCl3) δ 1.82 (s, 3H), 3.65 (s, 3H), 3.79 (d, 1H, J ) 13.5
Hz), 4.05 (d, 1H, J ) 13.5 Hz), 4.70 (s, 1H), 7.20-7.42 (m, 10H);
13C NMR (CDCl3) δ 19.4, 52.3, 59.9, 73.6, 127.9, 128.3, 128.6,
129.1, 129.2, 130.1, 133.8, 135.0, 168.8, 169.9. Anal. Calcd for
C18H19NO4: C, 68.99; H, 6.11; N, 4.47. Found: C, 69.02; H, 5.93;
N, 4.60.
N-(ter t-Bu toxyca r bon yl)-L-a la n in e Meth yl Ester (L-7a ).
The N-hydroxy-R-amino acid derivative L-6a (0.20 g, 0.80 mmol)
was treated as described above for the preparation of D-7a .
Column chromatography (90:10 hexane-diethyl ether) of the
crude product gave 0.151 g (93%) of L-7a as a solid. The physical
and spectroscopic data were identical to those of an authentic
sample (Aldrich, cat. no. 42,357-2).
(2S,3S)-N-Ben zyl-3-(h ydr oxyam in o)-1,2-O-isopr opyliden e-
3-p h en yl-1,2-p r op a n ed iol (10b). The nitrone 2 (0.94 g, 4
mmol) was treated as described above for the preparation of 3a
using diethyl aluminum chloride (4 mmol, 4.0 mL of a 1.0 M
solution in hexanes) as a Lewis acid and phenylmagnesium
bromide (6 mmol, 6.0 mL of a 1.0 M solution in Et2O) as a
Grignard reagent. 1H NMR analysis of the crude product
revealed a diastereoselectivity of 85%. Column chromatography
(80:20 hexane-diethyl ether) of that crude product gave 0.852
g (68%) of 10b as a white solid: mp 141-143 °C; [R]D -17.5 (c
N-(ter t-Bu toxyca r bon yl)-L-p h en ylglycin e Meth yl Ester
(L-7b). The N-hydroxy-R-amino acid derivative L-6b (0.20 g,
0.638 mmol) was treated as described above for the preparation
of D-7a . Column chromatography (80:20 hexane-diethyl ether)
of the crude product gave 0.159 g (94%) of L-7a as a white solid:
mp 111-113 °C; [R]D +133.1 (c 1.0, CHCl3) [lit.10 [R]D +135.7 (c
1
0.8, CHCl3)]; H NMR (CDCl3) δ 1.41 (s, 9H), 3.73 (s, 3H), 5.34
(d, 1H, J ) 7.3 Hz), 5.55 (d, 1H, J ) 7.3 Hz), 7.30-7.44 (m, 5H);
13C NMR (CDCl3) δ 28.3, 52.7, 57.5, 79.90, 127.2, 128.6, 129.1,
137.0, 154.8, 171.6. Anal. Calcd for C14H19NO4: C, 63.38; H,
7.22; N, 5.28. Found: C, 63.27; H, 7.15; N, 5.41.
1
1.0, CHCl3); H NMR (CDCl3) δ 1.24 (s, 3H), 1.29 (s, 3H), 3.52
(d, 1H, J ) 13.4 Hz), 3.67 (d, 1H, J ) 13.4 Hz), 3.70 (d, 1H, J )
6.7 Hz), 3.94 (dd, 1H, J ) 6.7, 8.4 Hz), 4.15 (dd, 1H, J ) 6.3, 8.4
Hz), 4.75 (dt, 1H, J ) 6.3, 6.7 Hz), 4.86 (bs, 1H, ex. D2O), 7.23-
7.43 (m, 10H); 13C NMR (CDCl3) δ 24.5, 26.5, 62.3, 68.3, 73.6,
76.4, 109.1, 127.3, 128.0, 128.2, 128.3, 129.3, 130.1, 136.3, 137.3.
Anal. Calcd for C19H23NO3: C, 72.82; H, 7.40; N, 4.47. Found:
C, 72.77; H, 7.60; N, 4.55.
Ack n ow led gm en t. Financial support was provided
by the MEC (DGES, Madrid, Spain). S.F. also thanks
MEC for a contract under the program Acciones para
la incorporacio´n a Espan˜a de Doctores y Tecnologos.
J O971913N